Richard Peck

Phase I Safety and Pharmacokinetic Trials of 1263W94, a Novel Oral Anti-Human Cytomegalovirus Agent, in Healthy and Human Immunodeficiency Virus-Infected Subjects

Laurene H. Wang, Richard Peck, Yin Yin et al. · Antimicrobial Agents and Chemotherapy · 2003 · 132 citations · Full text

Medicinal Chemistry, Adverse Events, Healthy Subjects +13

Model-Based Drug Development: The Road to Quantitative Pharmacology

Liping Zhang, Vikram Sinha, S. Thomas Forgue et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2006 · 109 citations

Medicine, Rational Drug Design, Quantitative Systems Pharmacology +3

Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors

Amita Patnaik, Anthony W. Tolcher, M. Beeram et al. · Cancer Chemotherapy and Pharmacology · 2015 · 65 citations

Molecular Pharmacology, Oncology, Medicine +9

Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins

Paul G. McNally, N I Jowett, JJ Kurinczuk et al. · Postgraduate Medical Journal · 1988 · 59 citations · Full text

The Effect of Propranolol on Glyceryltrinitrate-Induced Headache and Arterial Response

LL Thomsen, LL Thomsen, Pauline Williams et al. · Cephalalgia · 2004 · 59 citations